These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19885841)

  • 21. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
    Gadducci A; Cosio S; Tana R; Genazzani AR
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):12-27. PubMed ID: 18595727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
    Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B
    Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
    Polterauer S; Grimm C; Seebacher V; Concin N; Marth C; Tomovski C; Husslein H; Leipold H; Hefler-Frischmuth K; Tempfer C; Reinthaller A; Hefler L
    Oncologist; 2009 Oct; 14(10):979-85. PubMed ID: 19776095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
    Liu JF; Hirsch MS; Lee H; Matulonis UA
    Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
    J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival.
    Thomassen M; Jochumsen KM; Mogensen O; Tan Q; Kruse TA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):711-24. PubMed ID: 19441089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
    Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA2 alteration is important in clear cell carcinoma of the ovary.
    Goodheart MJ; Rose SL; Hattermann-Zogg M; Smith BJ; De Young BR; Buller RE
    Clin Genet; 2009 Aug; 76(2):161-7. PubMed ID: 19656163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clusterin overexpression and relapse-free survival in breast cancer.
    Yom CK; Woo HY; Min SY; Kang SY; Kim HS
    Anticancer Res; 2009 Oct; 29(10):3909-12. PubMed ID: 19846927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.
    Stock N; Chibon F; Binh MB; Terrier P; Michels JJ; Valo I; Robin YM; Guillou L; Ranchère-Vince D; Decouvelaere AV; Collin F; Birtwisle-Peyrottes I; Gregoire F; Aurias A; Coindre JM
    Am J Surg Pathol; 2009 Dec; 33(12):1850-9. PubMed ID: 19898221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary cytoreduction in epithelial ovarian cancer recurrence: a perspective from a regional cancer center in India.
    Rema PN; Suchetha S; Mathew AP; Mathew A; Sebastian P
    J Reprod Med; 2009 Aug; 54(8):506-10. PubMed ID: 19769197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23-year-old woman.
    Quddus MR; Rashid LB; Hansen K; Sung CJ; Lawrence WD
    Histopathology; 2009 May; 54(6):771-3. PubMed ID: 19438755
    [No Abstract]   [Full Text] [Related]  

  • 35. Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer.
    Cormio L; Tolve I; Annese P; Saracino A; Zamparese R; Sanguedolce F; Bufo P; Battaglia M; Selvaggi FP; Carrieri G
    Anticancer Res; 2009 Oct; 29(10):4201-4. PubMed ID: 19846973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intraperitoneal chemotherapy in ovarian carcinoma. Life prolonging in selected patients].
    Ottevanger PB
    Ned Tijdschr Geneeskd; 2009 Mar; 153(11):503-7. PubMed ID: 19402326
    [No Abstract]   [Full Text] [Related]  

  • 37. Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
    Fagotti A; Fanfani F; Vizzielli G; Gallotta V; Ercoli A; Paglia A; Costantini B; Vigliotta M; Scambia G; Ferrandina G
    Gynecol Oncol; 2010 Jan; 116(1):72-7. PubMed ID: 19846211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. StatBite: Ovarian cancer: risk of recurrence by stage of diagnosis.
    J Natl Cancer Inst; 2009 Sep; 101(18):1234. PubMed ID: 19738164
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of cancer drugs on survival: often poorly evaluated.
    Prescrire Int; 2009 Aug; 18(102):180-3. PubMed ID: 19746577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread.
    Robboy SJ; Shaco-Levy R; Peng RY; Snyder MJ; Donahue J; Bentley RC; Bean S; Krigman HR; Roth LM; Young RH
    Int J Gynecol Pathol; 2009 Sep; 28(5):405-22. PubMed ID: 19696610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.